Results 181 to 190 of about 1,765,782 (294)

Corrigendum to: ApoB100 remodeling and stiffened cholesteryl ester core raise LDL aggregation in familial hypercholesterolemia patients [Journal of Lipid Research 66/1 (2025) 100703]. [PDF]

J Lipid Res
La Chica Lhoëst MT, Martínez A, Garcia E, Dandurand J, Polishchuk A, Benitez-Amaro A, Cenarro A, Civeira F, Bernabé A, Vilades D, Escolà-Gil JC, Samouillan V, Llorente-Cortes V.   +12 more
europepmc   +1 more source

Comparative effectiveness of cholesteryl ester transfer protein (CETP) inhibitors on cardiovascular outcomes: A comprehensive Bayesian network meta-analysis and network meta-regression. [PDF]

Medicine (Baltimore)
Khalil I, Islam MR, Promi SA, Joy AD, Sayed MA, Acharjee D, Al-Shammari AS, Rahman MT, Abrar S, Bin Jamil TS, Taseen M, Biswas S, Mifty SK, Al-Badri SG, Debnath A, Hossain MI, Akter MM.   +16 more
europepmc   +1 more source

Dissecting the Structural Dynamics of Authentic Cholesteryl Ester Transfer Protein for the Discovery of Potential Lead Compounds: A Theoretical Study. [PDF]

Int J Mol Sci, 2023
Zhao Y, Hao D, Zhao Y, Zhang S, Zhang L, Yang Z.   +5 more
europepmc   +1 more source

Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects.

American Journal of Clinical Nutrition, 2009
Yuanyuan Qin, M. Xia, Jing Ma, Y. Hao, Jing Liu, HaiYing Mou, Li Cao, W. Ling   +7 more
semanticscholar   +1 more source

Cholesteryl Ester Transfer Protein Deficiency and Hyperalphalipoproteinemia. [PDF]

J Atheroscler Thromb
Inazu A.
europepmc   +1 more source

The cholesteryl ester transfer protein (CETP) raises cholesterol levels in the brain. [PDF]

J Lipid Res, 2022
Oestereich F, Yousefpour N, Yang E, Phénix J, Nezhad ZS, Nitu A, Vázquez Cobá A, Ribeiro-da-Silva A, Chaurand P, Munter LM.   +9 more
europepmc   +1 more source

Cholesteryl ester transfer protein inhibition with obicetrapib is associated with attenuated decline in kidney function in patients at high cardiovascular risk: Post hoc pooled results from the BROADWAY and BROOKLYN trials. [PDF]

Am J Prev Cardiol
Vogt L, Davidson MH, Szarek M, Kling D, Dicklin MR, Curcio D, Ditmarsch M, Hsieh A, Wicks DL, Ortiz N, Kastelein JJP.   +10 more
europepmc   +1 more source

Atorvastatin improves cisplatin sensitivity through modulation of cholesteryl ester homeostasis in breast cancer cells. [PDF]

Discov Oncol, 2022
Zipinotti Dos Santos D, Santos Guimaraes ID, Hakeem-Sanni MF, Cochran BJ, Rye KA, Grewal T, Hoy AJ, Rangel LBA.   +7 more
europepmc   +1 more source

Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease. [PDF]

J Prev Alzheimers Dis
Davidson MH, Szarek M, Scheltens P, Vijverberg E, Hsieh A, Ditmarsch M, Kling D, Curcio D, Nicholls SJ, Ray KK, Cummings JL, Kastelein JJ.   +11 more
europepmc   +1 more source

Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents? [PDF]

Cardiovasc Res, 2022
Nurmohamed NS, Ditmarsch M, Kastelein JJP.   +2 more
europepmc   +1 more source